VIPS II is an international multi-center NIH funded study that proposes to enroll 200 pediatric stroke cases and 200 pediatric stroke-free cases. Biological specimens, imaging, parent interviews and medical chart abstraction will be collected from all pediatric stroke cases. VIPS II aims to identify known and novel pathogens in children with AIS, and determine whether different pathogens (including unusual strains or combinations of pathogens) are associated with arteriopathic versus cardioembolic or idiopathic stroke. Link to Website. Link to pubmed.
Participating Sites: Boston’s Children’s Hospital (M. Rivkin) , Children’s Hospital of Philadelphia (B. Ichord), Children’s Mercy Kansas City (M. Sharma) , Children’s National Medical Center (P. Pergami), Cincinnati Children’s Hospital (J.M. Taylor), Cook Children’s Hospital (M. Torres), The Hospital of Sick Children (N. Dlamini), John Hopkins Children Center (R.Felling), Lurie Children’s Hospital of Chicago (J. Kurz), Oregon Health & Science University (J. Wilson), Phoenix Children’s Hospital (N. Friedman), Royal Children’s Hospital Melbourne (M. MacKay), Research Institute at Nationwide Children’s Hospital (W. Lo), Seattle Children’s Hospital (C. LeFond), Stanford Children’s Health (S. Lee & M. Wintermark), University of Calgary, Alberta Children’s Hospital (A. Kirton), University of Colorado, Denver (T. Bernard), University of Pittsburgh (D. Cummings), University of Tennessee, LeBonheur (T. Ridley-Pryor), The University of Texas Southwestern Medical Center (M. Dowling) and Vanderbilt University Medical Center (L. Jordan)
Keyword(s): Arterial Ischemic stroke, Infection, arteriopathy, pediatric, children
Are you seeking other sites to participate in research study? No
Contact information (if desired): Kathleen Colao, Research Manager,
